Go Deep
Lucid Diagnostics Inc.
Lucid Diagnostics Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 15,624 | -1.4 | 10.59 | 2.28 | 57.71 |
| Oct 2026 | 16,367 | -1.2 | 9.49 | 2.28 | 51.57 |
| Oct 2026 | 16,639 | -1.3 | 9.09 | 2.28 | 49.39 |
| Oct 2026 | 17,136 | -1.1 | 8.35 | 2.28 | 45.27 |
| Oct 2026 | 16,524 | -0.9 | 6.59 | 2.28 | 35.78 |
| Oct 2026 | 16,825 | -0.8 | 6.15 | 2.28 | 33.37 |
| Oct 2026 | 17,043 | -0.8 | 5.83 | 2.28 | 31.53 |
| Oct 2026 | 17,111 | -0.7 | 5.73 | 2.28 | 30.93 |
Lucid Diagnostics Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,474,000.0 | 1,256,000.0 | 1,504,000.0 | 1,211,000.0 |
| Net Profit | -11,687,000.0 | -13,909,000.0 | -16,266,000.0 | -10,397,000.0 |
| EPS | -0.1 | -0.2 | -0.1 | -0.1 |
Lucid Diagnostics Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 4,706,000.0 | 4,346,000.0 | 2,428,000.0 | 377,000.0 |
| Net Profit | -58,010,000.0 | -45,529,000.0 | -52,666,000.0 | -56,171,000.0 |
| EPS | -0.4 | -1.1 | -1.3 | -1.6 |
Lucid Diagnostics Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 40,445,000.0 | 30,715,000.0 | 27,270,000.0 | 32,509,000.0 | — |
| Total Liabilities | 29,509,000.0 | 25,324,000.0 | 29,581,000.0 | 9,462,000.0 | — |
| Total Equity | 10,936,000.0 | 5,391,000.0 | -2,311,000.0 | 23,047,000.0 | — |
Owes vs Owns
Lucid Diagnostics Inc. owed $0.72 for every $1 it owned in Jun 2026, up from $0.29 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.72× | 0.73× | 0.82× | 1.08× | 0.29× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Lucid Diagnostics Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 85.8%Receivables 1.6%Inventory 0.9%Fixed assets (tangible) 6.5%Intangible assets 0.8%Other assets 4.5%
How it's funded — Dec 2025
Short-term debt 59.3%Long-term debt 2.3%Payables 2.4%Other liabilities 8.9%Shareholders' equity 27.0%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 34.7 | 22.4 | 18.9 | 22.5 |
| Receivables | 0.6 | 0.4 | 0.0 | 0.0 |
| Inventory | 0.4 | 0.3 | 0.3 | 0.1 |
| Fixed assets (tangible) | 2.6 | 3.7 | 2.6 | 3.6 |
| Intangible assets | 0.3 | 0.7 | 1.4 | 3.4 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1.8 | 3.2 | 4.0 | 2.9 |
| Liabilities & equity | ||||
| Short-term debt | 24.0 | 18.6 | 13.9 | 1.0 |
| Long-term debt | 0.9 | 1.8 | 0.2 | 1.0 |
| Payables | 1.0 | 1.2 | 1.1 | 1.1 |
| Other liabilities | 3.6 | 3.7 | 14.3 | 6.4 |
| Shareholders' equity | 10.9 | 5.4 | -2.3 | 23.0 |
| Net tangible assets | 10.6 | 4.7 | -3.7 | 19.6 |
Lucid Diagnostics Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -46,485,000.0 | -44,140,000.0 | -32,817,000.0 | -29,685,000.0 | — |
| Investing Activities | -197,000.0 | -646,000.0 | -221,000.0 | -4,108,000.0 | — |
| Financing Activities | 59,029,000.0 | 48,248,000.0 | 29,460,000.0 | 2,611,000.0 | — |